ZA931645B - Antitumor compositions and methods of treatment - Google Patents

Antitumor compositions and methods of treatment

Info

Publication number
ZA931645B
ZA931645B ZA931645A ZA931645A ZA931645B ZA 931645 B ZA931645 B ZA 931645B ZA 931645 A ZA931645 A ZA 931645A ZA 931645 A ZA931645 A ZA 931645A ZA 931645 B ZA931645 B ZA 931645B
Authority
ZA
South Africa
Prior art keywords
treatment
methods
antitumor compositions
antitumor
compositions
Prior art date
Application number
ZA931645A
Other languages
English (en)
Inventor
Fariborz Mohamadi
Michael Marriott Spees
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA931645B publication Critical patent/ZA931645B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Furan Compounds (AREA)
ZA931645A 1992-03-13 1993-03-08 Antitumor compositions and methods of treatment ZA931645B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/850,531 US5169860A (en) 1992-03-13 1992-03-13 Antitumor compositions and methods of treatment

Publications (1)

Publication Number Publication Date
ZA931645B true ZA931645B (en) 1994-09-08

Family

ID=25308394

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA931645A ZA931645B (en) 1992-03-13 1993-03-08 Antitumor compositions and methods of treatment

Country Status (19)

Country Link
US (1) US5169860A (xx)
EP (1) EP0560554A2 (xx)
JP (1) JPH0649052A (xx)
KR (1) KR930019655A (xx)
CN (1) CN1076447A (xx)
AU (2) AU662605B2 (xx)
BR (1) BR9301137A (xx)
CA (1) CA2091207A1 (xx)
CZ (1) CZ36893A3 (xx)
FI (1) FI931085A (xx)
HU (1) HUT63830A (xx)
IL (1) IL104981A0 (xx)
MX (1) MX9301296A (xx)
MY (1) MY111178A (xx)
NO (1) NO930891L (xx)
NZ (1) NZ247083A (xx)
TW (1) TW215083B (xx)
YU (1) YU16893A (xx)
ZA (1) ZA931645B (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254582A (en) * 1992-02-05 1993-10-19 Eli Lilly And Company Antitumor compositions and methods
US5270329A (en) * 1992-12-10 1993-12-14 Eli Lilly And Company Antitumor compositions and methods of treatment
CA2110524A1 (en) * 1992-12-10 1994-06-11 Gerald Burr Grindey Antitumor compositions and methods of treatment
ZA941500B (en) * 1993-03-10 1995-09-04 Lilly Co Eli Antitumor compositions and methods of treatment
US5529999A (en) * 1994-03-04 1996-06-25 Eli Lilly And Company Antitumor compositions and methods of treatment
CO4410190A1 (es) 1994-09-19 1997-01-09 Lilly Co Eli 3-[4-(2-AMINOETOXI)-BENZOIL]-2-ARIL-6-HIDROXIBENZO [b] TIOFENO CRISTALINO
US5629425A (en) * 1994-09-19 1997-05-13 Eli Lilly And Company Haloalkyl hemisolvates of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-piperidinoethoxy)-benzoyl]benzo[b]thiophene
US5863936A (en) * 1995-04-18 1999-01-26 Geron Corporation Telomerase inhibitors
US6008377A (en) * 1996-03-19 1999-12-28 Eli Lilly And Company Synthesis of 3-[4-(2-aminoethoxy)-benzoyl]-2-aryl-6-hydroxy-benzo[B]thiophenes
EP1021437B1 (en) * 1996-08-22 2001-11-14 Dong Wha Pharmaceutical Industrial Co. Ltd. Arylsulfonylimidazolone derivatives as an antitumor agent
AU4799797A (en) * 1996-10-04 1998-04-24 Eli Lilly And Company Antitumor compositions and methods of treatment
ES2156550B1 (es) * 1999-04-19 2002-02-01 Univ Navarra Publica Derivados de benzo(b) tiofenosulfonamida-1,1-dioxido y su uso como agentes antineoplasicos.
JP4505876B2 (ja) * 1999-05-25 2010-07-21 東ソー株式会社 ４−ハロベンゾフラン誘導体及びその製造方法
TWI281916B (en) * 2001-10-25 2007-06-01 Lilly Co Eli Antitumor compounds and methods
US20050119318A1 (en) * 2003-10-31 2005-06-02 Hudyma Thomas W. Inhibitors of HCV replication
US8569364B2 (en) * 2007-11-28 2013-10-29 Sequoia Pharmaceuticals, Inc. 5-substituted benzofurans as inhibitors of cytochrome P450 2D6
KR101300702B1 (ko) * 2011-01-20 2013-08-26 대우조선해양 주식회사 탈가스 장치
CN103450149B (zh) * 2012-06-01 2015-10-14 中国科学院上海有机化学研究所 苯基噻吩磺酰胺类化合物及其制备方法和用途
CN104564805B (zh) * 2013-10-29 2017-11-10 海尔集团公司 一种离心风机的扇叶结构、离心风机及嵌入式空调内机
IL253661B2 (en) * 2015-02-16 2024-01-01 Univ Queensland Sulfonylureas bearing a pentagonal ring, pharmaceutical preparations and their uses
MA44729A (fr) 2016-04-18 2021-05-12 Novartis Ag Composés et compositions pour traiter des états associés à une activité de nlrp
MA56075A (fr) 2017-07-07 2022-04-06 Inflazome Ltd Nouveaux composés de sulfonamide carboxamide
LT3658539T (lt) 2017-07-24 2024-05-10 Novartis Ag Su nlrp veikla susijusių ligų gydymui skirti junginiai ir kompozicijos
BR112020003014A2 (pt) 2017-08-15 2020-07-28 Inflazome Limited sulfonilureias e sulfoniltioureias como inibidores de vnlrp3
US11926600B2 (en) 2017-08-15 2024-03-12 Inflazome Limited Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
WO2019034692A1 (en) 2017-08-15 2019-02-21 Inflazome Limited SULFONYLURATES AND SULFONYLTHIOURES AS INHIBITORS OF NLRP3
KR20200087759A (ko) 2017-11-09 2020-07-21 인플라좀 리미티드 신규한 설폰아마이드 카복스아마이드 화합물
WO2019166619A1 (en) 2018-03-02 2019-09-06 Inflazome Limited Novel compounds
CN113056451A (zh) * 2018-10-24 2021-06-29 诺华股份有限公司 用于治疗与nlrp活性相关的病症的化合物和组合物
CN109384764B (zh) * 2018-12-12 2021-09-03 中国科学院上海有机化学研究所 苯基噻吩磺酰胺类化合物、药物组合物、其制备方法和应用
WO2022022646A1 (zh) * 2020-07-29 2022-02-03 南京明德新药研发有限公司 含硒五元杂芳环化合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3083207A (en) * 1963-03-26 Indolinesulfonylureas
DE1144259B (de) * 1956-05-29 1963-02-28 Hoechst Ag Verfahren zur Herstellung von Sulfonylharnstoffen
US3097242A (en) * 1960-06-29 1963-07-09 Olin Mathieson Hydrindene sulfonylureas
DE1240866B (de) * 1961-06-29 1967-05-24 Heyden Chem Fab Verfahren zur Herstellung von Indolin-6-sulfonylharnstoffen
US3102121A (en) * 1961-06-29 1963-08-27 Olin Mathieson Novel cumaransulfonylureas and 2,3-dihydrothionaphthenesulfonylureas
GB1050447A (xx) * 1962-04-11
US3849110A (en) * 1963-01-07 1974-11-19 Lilly Co Eli Herbicidal method employing aryl-sulfonylureas or salts thereof
US3736122A (en) * 1969-04-10 1973-05-29 C Tung Method of controlling plant growth
AU1862083A (en) * 1982-09-02 1984-03-08 Duphar International Research B.V. Tumor growth inhibitors
CA1208561A (en) * 1984-01-19 1986-07-29 Marius S. Brouwer Pharmaceutical compositions containing benzoylurea compounds
US4845128A (en) * 1984-06-27 1989-07-04 Eli Lilly And Company N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides
GR862353B (en) * 1985-09-23 1987-01-19 Lilly Co Eli Anti-tumor method and compounds
CA1331464C (en) * 1987-05-12 1994-08-16 Eli Lilly And Company Anti-tumor method and compounds
ZA915371B (en) * 1990-07-17 1993-03-31 Lilly Co Eli Antitumor compositions and methods of treatment

Also Published As

Publication number Publication date
CN1076447A (zh) 1993-09-22
BR9301137A (pt) 1993-09-28
EP0560554A3 (xx) 1994-01-19
NZ247083A (en) 1995-09-26
NO930891L (no) 1993-09-14
US5169860A (en) 1992-12-08
FI931085A (fi) 1993-09-14
AU662605B2 (en) 1995-09-07
CZ36893A3 (en) 1994-04-13
HU9300688D0 (en) 1993-05-28
NO930891D0 (no) 1993-03-11
AU3519893A (en) 1993-09-16
JPH0649052A (ja) 1994-02-22
MX9301296A (es) 1993-10-01
TW215083B (xx) 1993-10-21
CA2091207A1 (en) 1993-09-14
AU4028995A (en) 1996-02-15
HUT63830A (en) 1993-10-28
IL104981A0 (en) 1993-07-08
EP0560554A2 (en) 1993-09-15
MY111178A (en) 1999-09-30
KR930019655A (ko) 1993-10-18
FI931085A0 (fi) 1993-03-11
YU16893A (sh) 1996-07-24

Similar Documents

Publication Publication Date Title
ZA931645B (en) Antitumor compositions and methods of treatment
EP0581581A3 (en) Bioadhesive treatment compositions and methods of use
AU3691793A (en) Gas well treatment compositions and methods
ZA915371B (en) Antitumor compositions and methods of treatment
GB9301802D0 (en) Manufacture and processing of components
SG44524A1 (en) Methods and compositions of treating malaria and other diseases
GB2269164B (en) Treatment of polyvinylchloride
GB9014307D0 (en) Method of treatment and compositions therefor
GB2294637B (en) Therapeutic compositions and methods of use
GB9010058D0 (en) Method and composition for the treatment of cancer
IL104755A0 (en) Treatment of glaucoma
GB9202196D0 (en) Method of treatment
ZA938897B (en) Antioxidant neuroprotective use of and method of treatment using hydroxycarbazole compounds
ZA936166B (en) Methods of treating cancer
EP0929540A4 (en) ANTI-TUMOR COMPOSITIONS AND THERAPEUTIC METHODS
PL303822A1 (en) Therapeutic compositions containing ipsapyrone and method of obtaining them
GB2250217B (en) Treatment of gas
GB9201391D0 (en) Method of treatment
EP0949916A4 (en) ANTI-TUMOR COMPOSITIONS AND THERAPEUTIC METHODS
GB9212535D0 (en) Treatment of boimass
GB2266241B (en) Treatment of pastures
GB9226032D0 (en) Treatment of cancer
AU4391093A (en) Compositions and methods for the prevention and treatment of thrombosis
GB9112552D0 (en) Method and composition for the treatment of cancer
GB9226252D0 (en) Method of treatment